On Demand: CCTA Operational Efficiencies: The Nurse Navigator Role and Other Practical Approaches to Program Growth-HeartFlow One Portfolio

HeartFlow One Portfolio

Pdf Summary

HeartFlow ONE is a comprehensive suite of AI-driven solutions designed to enhance the diagnosis and treatment of coronary artery disease (CAD) using coronary computed tomography angiography (CCTA). It is recognized by the American College of Cardiology/American Heart Association (ACC/AHA) Chest Pain Guidelines and is widely adopted across 500 hospitals, including 80% of the top 50 US heart hospitals.<br /><br />The HeartFlow Analysis includes FFRCT Analysis, RoadMapTM Analysis, and Plaque Analysis, providing a complete picture of coronary health to inform treatment decisions. The technology enables physicians to read CCTAs 25% faster and reach a 34% increase in inter-reader agreement. By utilizing advanced AI, HeartFlow helps identify and quantify plaque with 95% accuracy compared to intravascular ultrasound, leading to changes in treatment planning for two-thirds of patients.<br /><br />FFRCT Analysis offers lesion-specific assessment of fractional flow reserve (FFR) with superior accuracy, evidenced by a 0.94 AUC rating, assisting in optimal diagnosis and treatment plans for 97% of patients. The streamlined workflow ensures quick analysis turnaround, with median processing times of 1.5 hours, allowing timely clinical decisions.<br /><br />HeartFlow Analysis is FDA cleared in the US, CE Marked in Europe and the UK, and approved in Japan and Canada. It is intended to be used alongside a patient’s clinical history, symptoms, and other tests, while considering the clinician’s judgment. The analysis is tailored to enhance CCTA program growth with support from clinical, technical, operational, educational, and financial experts.<br /><br />The HeartFlow ONE platform aims to improve patient outcomes by facilitating earlier, life-saving care through accurate and non-invasive CAD assessment, establishing a new standard in cardiac diagnostics.

Keywords

HeartFlow ONE

AI-driven solutions

coronary artery disease

CCTA

FFRCT Analysis

plaque quantification

FDA cleared

cardiac diagnostics

treatment planning

clinical workflow